2012
DOI: 10.1021/sb2000287
|View full text |Cite
|
Sign up to set email alerts
|

The Organism Is the Product

Abstract: A new industry model is emerging where microbes are first developed by specialist organism engineering firms and then deployed by customers in specific application areas. It is now realistic for companies without prior fermentation experience to purchase and deploy an engineered organism to expand their business.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…Since the advances of synthetic biology are enabling the construction of increasingly complex controllable systems [12] and industrially relevant solutions [27], predictability has become a crucial point for the realization and debugging of customized technologies. With this work, we intend to provide useful data to support the predictable tuning of gene expression in recombinant E. coli cultures.…”
Section: Introductionmentioning
confidence: 99%
“…Since the advances of synthetic biology are enabling the construction of increasingly complex controllable systems [12] and industrially relevant solutions [27], predictability has become a crucial point for the realization and debugging of customized technologies. With this work, we intend to provide useful data to support the predictable tuning of gene expression in recombinant E. coli cultures.…”
Section: Introductionmentioning
confidence: 99%
“…The 'Standard European Vector Architecture' defines rules for plasmids with respect to restriction sites, overall plasmid architecture, and nomenclature that immensely facilitate the exchange of engineering back to the University of California at Berkeley and isoprene metabolism engineering in the laboratory of Jay Keasling [52] ) and Synthetic Genomics (going back to the earlier genome synthesis efforts of efforts around Craig Venter [9] ) had a bit of a mixed success, more recent endeavors such as Ginkgo Bioworks seem to be very successful in acquiring funding and attracting projects. [53] Complementing (and fueling) these efforts is a commercial DNA synthesis ecosystem in which competition and new technologies constantly reduce the cost of large scale DNA synthesis. [54] So in general, it is probably fair to say that Synthetic Biology has indeed been adopted into the world of commercial enterprise.…”
Section: The Chassis Problemmentioning
confidence: 99%